Drinalizumab
Drinalizumab is a humanized monoclonal antibody which it is used as an immunosuppresive drug and it is used to treat Type 1 diabetes.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
Drinalizumab is a humanized monoclonal antibody which it is used as an immunosuppresive drug and it is used to treat Type 1 diabetes.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH